WebEnrollment Form Fax: 1-800-604-6027 or E-mail: enrollment@arikares.com Please complete all fields on pages 1 and 3 to prevent any delays and include scanned copies of both sides of the patient’s insurance card (fields marked with an asterisk [*] are mandatory/required). Questions? Phone: 1-833-ARIKARE (1-833-274-5273) Alternate …
WebArikares Support Program Enrollment Form and Prescription (Rx) (First Shipment Includes Lamira® System) To get started, submit all pages of this form through Fax: 1-800-604-6027 or E-mail: enrollment@arikares.com Please complete all fields on page 1 and 3 to prevent any delays and include scanned copies of both sides of your insurance card
Resources for HCPs - ARIKAYCE
WebArikares Enrollment Form. To prescribe ARIKAYCE, this form must be completed. Patient signature is required for enrollment in Arikares. Submit via fax (1-800-604-6027) or email (enrollment@arikares.com).
Prescribing ARIKAYCE (amikacin liposome inhalation suspension)
WebTo prescribe ARIKAYCE, first complete the Arikares ® Enrollment Form with your patients. The Arikares Enrollment Form allows you to both prescribe ARIKAYCE and enroll your patients in the Arikares Support Program. A patient's signature on the Enrollment Form gives them access to support services.
MAC Resources | ARIKAYCE® (amikacin liposome inhalation …
WebArikares Enrollment Form. Download this form, fill it out, and take it to your doctor’s office to complete.
Support Sign-up | ARIKAYCE® (amikacin liposome inhalation …
WebSign up to receive support, resources, and financial assistance for your ARIKAYCE® treatment journey. See Prescribing & Safety Information, including Boxed Warnings.
WebPROGRAM ENROLLMENT • Complete the Arikares Enrollment Form enclosed or download an interactive form by visiting ArikaresEnrollmentForm.com - Submit all pages via fax (1-800-604-6027) or e-mail (enrollment@arikares.com) PAYER ACCESS EDUCATION • Patient Access Lead (PAL) is available to provide the most recent publicly available
FDA approves a new antibacterial drug to treat a serious lung …
WebThe U.S. Food and Drug Administration today approved a new drug, Arikayce (amikacin liposome inhalation suspension), for the treatment of lung disease caused by a group of bacteria,...
WebThe recommended dosage of ARIKAYCE in adults is once daily inhalation of the contents of one 590 mg/8.4 mL ARIKAYCE vial (590 mg of amikacin) using the Lamira Nebulizer System. Administer ARIKAYCE with the Lamira Nebulizer System only. ARIKAYCE should be at room temperature before use.
Arikayce: Side Effects, Cost, Dosage, Uses, and More - Healthline
WebMar 27, 2023 · Learn about side effects and more for Arikayce (amikacin). It’s a prescription drug used to treat Mycobacterium avium complex lung disease in certain adults.
Skip to content